Buyang Huanwu Decoction suppresses cardiac inflammation and fibrosis in mice after myocardial infarction through inhibition of the TLR4 signalling pathway

被引:8
作者
Zhang, Guoyong [1 ,2 ]
Han, Xin [1 ,2 ]
Xu, Tong [1 ,2 ]
Liu, Min [3 ]
Chen, Guanghong [1 ,2 ]
Xie, Lingpeng [2 ,4 ]
Xu, Honglin [2 ,5 ]
Hua, Yue [2 ]
Pang, Mingjie [1 ,2 ]
Hu, Changlei [1 ,2 ]
Wu, Yuting [6 ]
Liu, Bin [7 ]
Zhou, Yingchun [1 ,2 ,8 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Tradit Chinese Med, ZengCheng Branch, Guangzhou 511300, Peoples R China
[2] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou 510515, Peoples R China
[3] Southern Med Univ, Sch Publ Hlth, Dept Pathogen Biol, Guangzhou 510515, Peoples R China
[4] Southern Med Univ, Integrated Hosp Tradit Chinese Med, Canc Ctr, Dept Hepatol, Guangzhou 510315, Peoples R China
[5] Southern Med Univ, Affliated Dongguan Hosp, Dongguan Peoples Hosp, Dept geratol, Dongguan 523058, Peoples R China
[6] Binzhou Med Univ Hosp, Binzhou 256603, Peoples R China
[7] Guangzhou Med Univ, Affiliated Hosp 2, Dept Tradit Chinese Med, Guangzhou 510260, Peoples R China
[8] Southern Med Univ, Nanfang Hosp, Sch Tradit Chinese Med, Dept Tradit Chinese Med,ZengCheng Branch, Guangzhou 510515, Peoples R China
基金
中国国家自然科学基金;
关键词
Buyang huanwu decoction; Heart failure; TLR4; NF-kappa B; NLRP3; inflammasome; NF-KAPPA-B; FIBROBLASTS; DISEASE;
D O I
10.1016/j.jep.2023.117388
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: It has been reported that cardiac inflammation and fibrosis participate in the development of heart failure (HF) following myocardial infarction (MI). Anti-inflammatory and anti-fibrotic treatments exhibit therapeutic efficacy in MI. Buyang Huanwu Decoction (BYHWD) has cardioprotective prop-erties. However, whether BYHWD regulates cardiac inflammation and fibrosis in HF after MI, and the underlying mechanisms, are still unknown.Aim of the study: This study aimed to explore the effects and potential mechanisms of BYHWD on cardiac inflammation and fibrosis after MI.Materials and methods: An MI model was constructed through ligation of the left anterior descending coronary artery (LAD) in mice. The cardioprotective effects of BYHWD were determined by echocardiography, Masson trichrome staining, wheat germ agglutinin (WGA) staining and haematoxylin and eosin (HE) staining. The effects of BYHWD on inflammation and fibrosis, and on the TLR4 signalling pathway, were explored through immu-nohistochemistry (IHC), Western blot (WB), enzyme-linked immunosorbent assay (ELISA) and quantitative reverse transcription polymerase chain reaction (qRT-PCR) in vivo. Next, the effects of BYHWD on primary cardiac fibroblasts (CFs) inflammation and collagen synthesis, and on the TLR4 signalling pathway, were detected using WB, immunofluorescence (IF) and qRT-PCR in vitro. In addition, the suppression and over-expression of TLR4 in CFs were further explored. Results: BYHWD dose-dependently reduced cardiac inflammation, fibrosis and ventricular dysfunction. The expression levels of collagen I/III, IL-1 beta and IL-18, as well as critical proteins in the TLR4 signalling pathway and the NLRP3 inflammasome, were suppressed by BYHWD in the in vivo experiment. BYHWD inhibited CFs inflammation and collagen synthesis, as well as critical proteins in the TLR4 signalling pathway and the NLRP3 inflammasome, in the in vitro experiment. TLR4 suppression mitigated these inhibitory effects of BYHWD while overexpression of TLR4 markedly reversed these inhibitory effects of BYHWD.Conclusion: BYHWD exerts anti-inflammatory and anti-fibrotic effects in mice after MI, and suppresses CFs inflammation and collagen synthesis through suppression of the TLR4 signalling pathway.
引用
收藏
页数:17
相关论文
共 59 条
[1]   Acute Myocardial Infarction [J].
Anderson, Jeffrey L. ;
Morrow, David A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (21) :2053-2064
[2]   Inflammation and fibrosis in murine models of heart failure [J].
Bacmeister, Lucas ;
Schwarzl, Michael ;
Warnke, Svenja ;
Stoffers, Bastian ;
Blankenberg, Stefan ;
Westermann, Dirk ;
Lindner, Diana .
BASIC RESEARCH IN CARDIOLOGY, 2019, 114 (03)
[3]   The NF-κB regulatory network [J].
Brasier, Allan R. .
CARDIOVASCULAR TOXICOLOGY, 2006, 6 (02) :111-130
[4]   The molecular basis of the host response to lipopolysaccharide [J].
Bryant, Clare E. ;
Spring, David R. ;
Gangloff, Monique ;
Gay, Nicholas J. .
NATURE REVIEWS MICROBIOLOGY, 2010, 8 (01) :8-14
[5]   Elabela ameliorates doxorubicin-induced cardiotoxicity by promoting autophagic flux through TFEB pathway [J].
Chen, Deshu ;
Yu, Wenjie ;
Zhong, Chongbin ;
Hong, Qingqing ;
Huang, Guanlin ;
Que, Dongdong ;
Wang, Yuxi ;
Yang, Yashu ;
Rui, Bowen ;
Zhuang, Zhenyu ;
Liang, Miaoyuan ;
Ye, Zhicheng ;
Yan, Xin ;
Lv, Jiankun ;
Zhang, Ronghua ;
Yan, Jing ;
Yang, Pingzhen .
PHARMACOLOGICAL RESEARCH, 2022, 178
[6]   Calycosin reduces myocardial fibrosis and improves cardiac function in post-myocardial infarction mice by suppressing TGFBR1 signaling pathways [J].
Chen, Guanghong ;
Xu, Honglin ;
Xu, Tong ;
Ding, Wenjun ;
Zhang, Guoyong ;
Hua, Yue ;
Wu, Yuting ;
Han, Xin ;
Xie, Lingpeng ;
Liu, Bin ;
Zhou, Yingchun .
PHYTOMEDICINE, 2022, 104
[7]   Buyanghuanwu Decoction alleviated pressure overload induced cardiac remodeling by suppressing Tgf-β/Smads and MAPKs signaling activated fibrosis [J].
Chen, Huihua ;
Song, Haiyan ;
Liu, Xiao ;
Tian, Jing ;
Tang, Wenzhu ;
Cao, Tongtong ;
Zhao, Pei ;
Zhang, Chen ;
Guo, Wei ;
Xu, Ming ;
Lu, Rong .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 95 :461-468
[8]   Buyang Huanwu Decoction ameliorates atherosclerosis by regulating TGF-β/Smad2 pathway to promote the differentiation of regulatory T cells [J].
Chen, Shujing ;
Wang, Yuan ;
Liang, Chunxiao ;
Li, Jin ;
Li, Yuhong ;
Wu, Qi ;
Liu, Zhijian ;
Pang, Xiaoli ;
Chang, Yan-xu .
JOURNAL OF ETHNOPHARMACOLOGY, 2021, 269
[9]   Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals [J].
Conrad, Nathalie ;
Judge, Andrew ;
Tran, Jenny ;
Mohseni, Hamid ;
Hedgecott, Deborah ;
Crespillo, Abel Perez ;
Allison, Moira ;
Hemingway, Harry ;
Cleland, John G. ;
McMurray, John J. V. ;
Rahimi, Kazem .
LANCET, 2018, 391 (10120) :572-580
[10]   Cardiac fibrosis [J].
Frangogiannis, Nikolaos G. .
CARDIOVASCULAR RESEARCH, 2021, 117 (06) :1450-1488